CD4+ Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis.

Saved in:
Bibliographic Details
Title: CD4+ Th1 and Th17 responses and multifunctional CD8 T lymphocytes associated with cure or disease worsening in human visceral leishmaniasis.
Authors: de Franca MNF; Laboratory of Biology and Immunology of Cancer and Leishmania, Department of Morphology, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil., Rodrigues LS; Laboratory of Biology and Immunology of Cancer and Leishmania, Department of Morphology, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil., Barreto AS; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Division of Immunology and Molecular Biology Laboratory, University Hospital/Empresa Brasileira de Serviços Hospitalares (EBSERBH), Federal University of Sergipe, Aracaju, Sergipe, Brazil., da Cruz GS; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Division of Immunology and Molecular Biology Laboratory, University Hospital/Empresa Brasileira de Serviços Hospitalares (EBSERBH), Federal University of Sergipe, Aracaju, Sergipe, Brazil., Aragão-Santos JC; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Department of Physical Education, Federal University of Sergipe, Aracaju, Sergipe, Brazil., da Silva AM; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Department of Medicine, Federal University of Sergipe, Aracaju, Sergipe, Brazil., de Jesus AR; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Division of Immunology and Molecular Biology Laboratory, University Hospital/Empresa Brasileira de Serviços Hospitalares (EBSERBH), Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe, Brazil., Palatnik-de-Sousa CB; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Institute of Microbiology Paulo de Góes, Federal University of Rio de Janeiro, Immunology Investigative Institute (III), Insititutos nacionais de Ciência e Tecnologia (INCT), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Rio de Janeiro, Brazil.; Graduate Program in Vegetal Biotechnology and Bioprocesses, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil., de Almeida RP; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Division of Immunology and Molecular Biology Laboratory, University Hospital/Empresa Brasileira de Serviços Hospitalares (EBSERBH), Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Department of Medicine, Federal University of Sergipe, Immunology Investigative Institute (III), INCT, CNPq, Aracaju, Sergipe, Brazil., Corrêa CB; Laboratory of Biology and Immunology of Cancer and Leishmania, Department of Morphology, Federal University of Sergipe, Aracaju, Sergipe, Brazil.; Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Sergipe, Brazil.
Source: Frontiers in immunology [Front Immunol] 2024 Feb 12; Vol. 15, pp. 1277557. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2024.1277557